{"id":"https://openalex.org/W2159529406","doi":null,"title":"Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.","display_name":"Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.","publication_year":1989,"publication_date":"1989-08-15","ids":{"openalex":"https://openalex.org/W2159529406","mag":"2159529406","pmid":"https://pubmed.ncbi.nlm.nih.gov/2472883"},"language":"en","primary_location":{"id":"pmid:2472883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2472883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069644669","display_name":"Nancy E. Kemeny","orcid":"https://orcid.org/0000-0002-0929-9542","observed_orcids":["https://orcid.org/0000-0002-0929-9542"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N Kemeny","raw_affiliation_strings":["Department of Developmental Chemotherapy, Memorial Sloan Kettering Cancer Institute, New York 10021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Developmental Chemotherapy, Memorial Sloan Kettering Cancer Institute, New York 10021","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063903410","display_name":"Andrew M. Schneider","orcid":"https://orcid.org/0000-0001-5414-8244","observed_orcids":["https://orcid.org/0000-0001-5414-8244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Schneider","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"D S Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D S Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088519031","display_name":"Joseph R. Colofiore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Colofiore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111437912","display_name":"Robert C. Sawyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R C Sawyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114096449","display_name":"Susan Derby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Derby","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036471248","display_name":"Barbara Salvia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Salvia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6676,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.74736952,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"49","issue":"16","first_page":"4636","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8363999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8363999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.06390000134706497,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-phosphonacetyl-l-aspartate","display_name":"N-(phosphonacetyl)-L-aspartate","score":0.996999979019165},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9760000109672546},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":1.0},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9290000200271606},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.8289999961853027},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6449999809265137},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5149999856948853},{"id":"https://openalex.org/keywords/phosphoribosyl-pyrophosphate","display_name":"phosphoribosylpyrophosphate","score":0.5070000290870667},{"id":"https://openalex.org/keywords/rna-incorporation","display_name":"RNA incorporation","score":0.6890000104904175},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.5600000023841858},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.5630000233650208},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.9284709095954895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7439261078834534},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.7079129219055176},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6525850296020508},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6358456015586853},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5215446949005127},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.52049320936203},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5083467364311218},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.49386531114578247},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.45015448331832886},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3828507661819458},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3278658390045166},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3276296854019165}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001224","descriptor_name":"Aspartic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001224","descriptor_name":"Aspartic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010428","descriptor_name":"Pentosephosphates","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010746","descriptor_name":"Phosphonoacetic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010746","descriptor_name":"Phosphonoacetic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010754","descriptor_name":"Phosphoribosyl Pyrophosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2472883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2472883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2159529406","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2472883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G133703602","display_name":"CLINICAL DEVELOPMENT OF ANTICANCER AGENTS","funder_award_id":"n01cm057732-004","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2549390889","display_name":"CANCER THERAPY WITH BIOCHEMICAL MODULATORS AND CSFS","funder_award_id":"P01CA025842","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1479960751","https://openalex.org/W1520854244","https://openalex.org/W1524243863","https://openalex.org/W1548032098","https://openalex.org/W1575223772","https://openalex.org/W1598009345","https://openalex.org/W1878265365","https://openalex.org/W1964768968","https://openalex.org/W1999471341","https://openalex.org/W2040632920","https://openalex.org/W2114605359","https://openalex.org/W2114975594","https://openalex.org/W2139040913","https://openalex.org/W2258295221","https://openalex.org/W2271306081","https://openalex.org/W2397108296","https://openalex.org/W2397727482","https://openalex.org/W2398447982"],"related_works":["https://openalex.org/W2126575638","https://openalex.org/W2262195542","https://openalex.org/W1985273495","https://openalex.org/W2115794606","https://openalex.org/W2064803636","https://openalex.org/W4244137627","https://openalex.org/W2005905993","https://openalex.org/W2079815946","https://openalex.org/W2114975594","https://openalex.org/W2165324981"],"abstract_inverted_index":{"Based":[0],"on":[1,25,160],"an":[2,32],"animal":[3],"model":[4],"to":[5,37,54,59,70,183,194],"improve":[6],"the":[7,109,140,161,198,203],"antitumor":[8],"activity":[9],"of":[10,17,57,74,80,128,132,200,205],"5-fluorouracil":[11],"(FUra),":[12],"a":[13,47],"Phase":[14],"I":[15],"study":[16],"N-(phosphonacetyl)-L-aspartate,":[18],"methotrexate,":[19],"FUra,":[20],"and":[21,42,88,105,124,150,180],"leucovorin":[22],"was":[23,29,44,99,115,146],"conducted":[24],"44":[26],"patients.":[27,134],"Methotrexate":[28],"given":[30,45,65],"in":[31,52,130,139,156,176,185],"intermediate":[33],"dose":[34,49,204],"(250":[35,50],"mg/m2)":[36,51],"overcome":[38],"potential":[39],"drug":[40],"resistance,":[41],"N-(phosphonacetyl)-L-aspartate":[43],"at":[46],"low":[48],"order":[53],"allow":[55],"escalation":[56],"FUra":[58,69,75],"toxicity.":[60,107],"These":[61],"two":[62],"drugs":[63],"were":[64,82,136,174],"24":[66,168],"h":[67,169],"before":[68],"enhance":[71],"maximal":[72],"incorporation":[73],"into":[76],"RNA.":[77],"Two":[78],"schedules":[79],"administration":[81],"used;":[83],"one":[84,89,147],"every":[85,95,141],"other":[86,96,142],"week":[87,97,143],"weekly":[90,110,162],"for":[91,111,163],"2":[92,112,164],"weeks.":[93],"The":[94],"schedule":[98,114],"well":[100],"tolerated,":[101],"with":[102,118,153,197],"minimal":[103],"gastrointestinal":[104],"hematological":[106],"However,":[108],"weeks":[113,165],"more":[116],"toxic":[117],"increased":[119,181],"mucositis,":[120],"diarrhea":[121],"requiring":[122],"therapy,":[123],"decreased":[125],"performance":[126],"status":[127],"20%":[129],"4":[131],"6":[133],"There":[135,145],"no":[137],"responders":[138],"schedule.":[144,166],"partial":[148],"response":[149],"three":[151],"patients":[152,159],"stable":[154],"disease":[155],"four":[157],"evaluable":[158],"At":[167],"post-N-(phosphonacetyl)-L-aspartate-methotrexate":[170],"treatment,":[171],"PRPP":[172],"levels":[173],"doubled":[175],"bone":[177],"marrow":[178],"biopsies,":[179],"2.5-":[182],"25-fold":[184],"tumor":[186],"biopsies.":[187],"We":[188],"have":[189],"currently":[190],"added":[191],"uridine":[192],"rescue":[193],"this":[195],"combination":[196],"hope":[199],"further":[201],"escalating":[202],"FUra.":[206]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}